Winchester, MA, United States of America

J Keith Joung

USPTO Granted Patents = 75 (Patent Applications = 38)

CIPO Patents = 5 (Patent Applications = 21)

EPO Patents = 16 (Patent Applications = 46)

Average Co-Inventor Count = 2.5

ph-index = 18

Forward Citations = 1,333(Granted Patents)

Forward Citations (Not Self Cited) = 1,150(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Cambridge, MA (US) (2021)
Winchester, MA (US) (1999 - 2024)

Company Filing History:

70 out of 2,893

The General Hospital Corporation

Massachusetts Institute of Technology

patents

4. 1 out of 81

Fox Chase Cancer Center

Beam Therapeutics Inc.

patents

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

Areas of Expertise:

Virus-Like Particles

CRISPR-Cas9 Nucleases

Gene Regulation

Base Editing Technologies

Nuclease-Induced Repair

RNA-Guided Targeting

Genome Editing Specificity

TAL-Tet1 Fusion Proteins

Genomewide Identification

In Vitro Assays

Multiplex Guide RNAs

Transcription Activator Like Effectors

75 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12404525 - Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells (2025-09-02),

2. 12351815 - Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells (2025-07-08),

3. 12351814 - Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells (2025-07-08),

4. 12319938 - Enhanced virus-like particles and methods of use thereof for delivery to cells (2025-06-03),

5. 12286641 - Methods for increasing efficiency of nuclease-induced homology-directed repair (2025-04-29),

6. 12241096 - Engineered CRISPR-Cas9 nucleases with altered PAM specificity (2025-03-04),

7. 12202861 - Inducible, tunable, and multiplex human gene regulation using CRISPR-Cpf1 (2025-01-21),

8. 12180520 - Engineered CRISPR-Cas9 nucleases with altered PAM specificity (2024-12-31),

9. 12173339 - Variants of Cpf1 (Cas12a) with altered PAM specificity (2024-12-24),

10. 12152254 - TAL-Tet1 fusion proteins and methods of use thereof (2024-11-26),

11. 12133884 - Methods of substituting pathogenic amino acids using programmable base editor systems (2024-11-05),

12. 12104207 - Genomewide unbiased identification of DSBs evaluated by sequencing (GUIDE-Seq) (2024-10-01),

13. 12065668 - RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci (2024-08-20),

14. 11976324 - Highly sensitive in vitro assays to define substrate preferences and sites of nucleic-acid binding, modifying, and cleaving agents (2024-05-07),

15. 11946040 - Adenine DNA base editor variants with reduced off-target RNA editing (2024-04-02),

Title: The Innovative Journey of J Keith Joung

Introduction: J Keith Joung is a renowned inventor hailing from Winchester, MA (US). He has made significant contributions to the field of biotechnology and genetics through his groundbreaking inventions and patents.

Latest Patents: J Keith Joung holds several patents in the field of genome editing technologies, including CRISPR-based systems for precise gene editing and manipulation. His innovative work has revolutionized the way genetic research is conducted.

Career Highlights: With a background in molecular biology and biochemistry, J Keith Joung has established himself as a leading figure in the field of genome editing. He has published numerous research papers and has been recognized with prestigious awards for his contributions to science and technology.

Collaborations: Throughout his career, J Keith Joung has collaborated with top research institutions, universities, and biotechnology companies to further advance the field of genetic engineering. His collaborative efforts have led to the development of cutting-edge technologies with far-reaching implications.

Conclusion: J Keith Joung's passion for innovation and his relentless pursuit of scientific excellence have solidified his reputation as a trailblazer in the field of biotechnology. His work continues to inspire future generations of inventors and researchers to push the boundaries of what is possible in the world of genetics.

This text is generated by artificial intelligence and may not be accurate.